There has been an endless “war” between pathogen organisms armed with the ability to establish new, genetically based ...
The integration of artificial intelligence (AI) into drug discovery is revolutionizing pharmaceutical research by providing sophisticated tools for understanding and predicting complex biological ...
Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...
The approach, published on 23 October in Science, builds on a trend that is sweeping the field of drug discovery: the use of ...
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...
While some AI-designed drugs have made it to clinical trials, none of them have been approved. Why has it been harder than ...
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. This Account discusses recent progress and challenges in binding free energy ...
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results